PPM1D and myeloid neoplasm: PPM1D variants were identified in 7.8% (13 variants in 11 of 141 evaluable patients), were exclusively seen at low levels (≤6% variant allele fraction [VAF]), and were not observed in the setting of a myeloid neoplasm.